CHM chimeric therapeutics limited

Ann: US patent allowed for CHM CDH17 technology, page-6

  1. 1,360 Posts.
    lightbulb Created with Sketch. 213
    Ever looked at patents? For my sins I have spent more time than I wish reading patents. Sometimes they're illuminating. Other times they're baffling. But this one really takes a second glance.
    The allowed patent application 17/050,299, entitled "Compositions and Methods for Retrieving Tumor-related Antibodies and Antigens," provides robust intellectual property protection for Chimeric's CHM CDH17 CAR-T therapy,
    https://hotcopper.com.au/data/attachments/6899/6899885-a3db73615e92bf3ba46d692dc1f6ee42.jpg
    Now that is an odd diagram for a CAR T patent!

    The background section is a real head scratcher. Hope someone's pulling the USPTO's leg here.
    https://hotcopper.com.au/data/attachments/6899/6899895-475439d8cb314a6197b0ea321a816e6c.jpg
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $15.69K 3.919M

Buyers (Bids)

No. Vol. Price($)
26 21936206 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 24685267 27
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.